Moleculin Biotech CEO Klemp to speak at Maxim Growth Summit oncology panel
MBRX•Moleculin Biotech will present at the 2026 Maxim Growth Summit in New York on Oct. 14, with CEO Walter Klemp scheduled for an oncology panel from 9:00 a.m. to 10:00 a.m. ET.
1. Summit appearance
Moleculin Biotech CEO Walter Klemp is scheduled to participate in the Advances in Oncology panel at the 2026 Maxim Growth Summit in New York on Oct. 14. The discussion is set to focus on the company’s oncology pipeline, including Annamycin’s Phase 2/3 MIRACLE trial in relapsed or refractory AML.
